Methylprednisolone Sodium Succinate (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Methylprednisolone Sodium Succinate drug offered from Sagent Pharmaceuticals. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: Methylprednisolone Sodium Succinate
SUBSTANCE NAME: METHYLPREDNISOLONE SODIUM SUCCINATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-03-15
END MARKETING DATE: 0000-00-00


Methylprednisolone Sodium Succinate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethylprednisolone Sodium Succinate from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/mL)
START MARKETING DATE: 2017-03-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-807_0bf9d0ea-b703-4eca-aab3-198f495ce63c
PRODUCT NDC: 25021-807
APPLICATION NUMBER: ANDA040888

Other METHYLPREDNISOLONE SODIUM SUCCINATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal BiosciencesMethylprednisolone Sodium Succinate
AuroMedics Pharma LLCMethylprednisolone Sodium Succinate
Cardinal HealthMethylprednisolone Sodium Succinate
Fresenius Kabi USA, LLCMethylprednisolone Sodium Succinate
General Injectables & Vaccines, IncSolu-Medrol
Pharmacia and Upjohn Company LLCSOLU-MEDROL
Sagent PharmaceuticalsMethylprednisolone Sodium Succinate
Sina Health IncSOLU-MEDROL
US MedSource, LLCSOLU-MEDROL